EPFL researchers have uncovered how transcription factor dosage reshapes cell identity, showing that even small differences in dose can steer cells toward completely different fates. Their findings ...

In recent years, we have come to appreciate that loss or dysfunction of insulin-producing islet beta cells underlies virtually all major forms of diabetes mellitus. In type 1 diabetes, beta cells ...

Studies have shown that cancer cells can 'trick' the immune system into believing they are healthy and prevent themselves ...

Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...

APRIL 16, 2025, NEW YORK – A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time ...

Cartilage is the body’s most stubborn tissue. Once it wears away, it’s usually gone for good. This biological dead-end is the ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and ...

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American NEW YORK—Despite a cloud of regulatory ...

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...